Open comparison →
STRUCTURED COMPARISON
Build a comparison
Choose two categories from the same family. The same properties, equal visual weight, sources next to the claims they support.
STRUCTURED COMPARISON
Choose two categories from the same family. The same properties, equal visual weight, sources next to the claims they support.
Beverages
The review separately examines how the strength of evidence is graded in nutrition science and reaches a consistent conclusion: cohort studies of clinical outcomes and trials of risk factors give the same answer.
Beyond the disagreement between trials and cohorts there is a second difficulty: sweeteners are metabolised differently from one another, and extending a finding from one substance to all the rest is not warranted. Long-term human data is insufficient, and part of the conclusions rest on rodent experiments.
The review states its conclusion more strongly than nutrition science usually allows: cohort data on clinical outcomes together with trials on risk factors support an aetiological role of sugar-sweetened drinks in weight gain and cardiometabolic disease. Habitual intake is linked to a raised risk of type 2 diabetes, cardiovascular disease and some cancers.
In randomised trials sweeteners produced a reduction in adiposity measures. In prospective cohorts their intake is associated with increased adiposity and chronic disease risk. This is not a dispute over details but a disagreement between kinds of study, and the platform takes no side between them.
A systematic review of 21 studies of taxes on such drinks across countries of different income levels: of sixteen selected studies only two did not show consumption, sales and purchases falling as price rose. In eight of thirteen, a fall in overweight prevalence was also expected.
The World Health Organization recommends that sweeteners not be used as a means of weight control or of reducing the risk of non-communicable diseases. The recommendation is labelled conditional — that is its own marker of strength, not the platform assessment. It was issued in the face of disagreement between trials and cohorts, not agreement.
Counted for this table only, not for the whole site.
The sides differ not only in composition but in how far the research agrees with itself. For sugar-sweetened drinks, cohort data on clinical outcomes and trials of risk factors point the same way, and the review speaks of an aetiological role in weight gain and cardiometabolic disease. For sweetener drinks the two kinds of study answer differently: in randomised trials adiposity measures fell, while in prospective cohorts intake is associated with increased adiposity and chronic disease risk. It was in the face of that disagreement that the World Health Organization recommended sweeteners not be used for weight control, labelling the recommendation conditional. To this is added what blocks generalisation: sweeteners are metabolised differently from one another, and a finding for one cannot be carried to all.
FREQUENTLY EXPLORED
Evidence reviewed: September 3, 2026
Sources are reviewed by the CONTRAST editorial team. External links open in a new tab.